Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
McKesson
Federal Trade Commission
US Army
Chubb
Fuji
US Department of Justice
Deloitte
Chinese Patent Office
Express Scripts

Generated: October 18, 2017

DrugPatentWatch Database Preview

Dihydroergotamine mesylate - Generic Drug Details

« Back to Dashboard

What are the generic sources for dihydroergotamine mesylate and what is the scope of dihydroergotamine mesylate patent protection?

Dihydroergotamine mesylate
is the generic ingredient in four branded drugs marketed by Hikma Pharms, Valeant, West-ward Pharms Int, Paddock Llc, and Novartis, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for dihydroergotamine mesylate. Five suppliers are listed for this compound.

Summary for Generic Name: dihydroergotamine mesylate

US Patents:0
Tradenames:4
Applicants:5
NDAs:6
Drug Master File Entries: see list5
Suppliers / Packagers: see list5
Bulk Api Vendors: see list49
Clinical Trials: see list528
Patent Applications: see list851
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dihydroergotamine mesylate at DailyMed

Pharmacology for Ingredient: dihydroergotamine mesylate

Ingredient-typeErgotamines
Drug ClassErgotamine Derivative
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant
D.H.E. 45
dihydroergotamine mesylate
INJECTABLE;INJECTION005929-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Novartis
EMBOLEX
dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride
INJECTABLE;INJECTION018885-001Nov 30, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
EMBOLEX
dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride
INJECTABLE;INJECTION018885-002Nov 30, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant
MIGRANAL
dihydroergotamine mesylate
SPRAY, METERED;NASAL020148-001Dec 8, 1997RXYesYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
DIHYDROERGOTAMINE MESYLATE
dihydroergotamine mesylate
INJECTABLE;INJECTION040453-001Jun 9, 2003APRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
DIHYDROERGOTAMINE MESYLATE
dihydroergotamine mesylate
INJECTABLE;INJECTION206621-001Sep 15, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
DIHYDROERGOTAMINE MESYLATE
dihydroergotamine mesylate
INJECTABLE;INJECTION040475-001Apr 28, 2003APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: dihydroergotamine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant
MIGRANAL
dihydroergotamine mesylate
SPRAY, METERED;NASAL020148-001Dec 8, 1997► Subscribe► Subscribe
Valeant
MIGRANAL
dihydroergotamine mesylate
SPRAY, METERED;NASAL020148-001Dec 8, 1997► Subscribe► Subscribe
Valeant
MIGRANAL
dihydroergotamine mesylate
SPRAY, METERED;NASAL020148-001Dec 8, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Dow
QuintilesIMS
Mallinckrodt
Argus Health
McKinsey
Fish and Richardson
Accenture
Novartis
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot